Added to YB: 2026-06-08
Pitch date: 2026-06-04
BAYN.DE [neutral]
Bayer Aktiengesellschaft
+2.03%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
Market Cap
EUR 35.5B
Pitch Price
EUR 35.44
Price Target
N/A
Dividend
0.30%
EV/EBITDA
6.49
P/E
-16.48
EV/Sales
1.50
Sector
Pharmaceuticals
Category
special_situation
Bayer (BAYN Germany): Legal milestones approach as settlement uncertainty drives volatility
BAYN.DE (update): Shares pressured as settlement approval uncertainty rises. Glyphosate deal now faces review in skeptical San Francisco federal court, not just Missouri (preliminary approval granted). Key dates: 4 Jun opt-in deadline, 9 Jul final ruling, late-Jun/Jul SCOTUS Durnell case. Volatility ahead; resolution would lift legal overhang and refocus on fundamentals.
Read full article (2 min)